Interview: Eoin Vaughan – CEO; Dermot Gildea – Director of Life…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key…
Address: A Menarini Pharmaceuticals Ireland Ltd
Castlecourt
Monkstown Farm
Monkstown
Co Dublin,Ireland
Tel: 353 1284 6744
Besides Italy, where Menarini is one of the leading pharmaceutical groups, sales are mainly concentrated in Europe: Austria, Benelux, France, Germany, United Kingdom, Greece, Ireland, Portugal, Spain, Turkey and Switzerland. Menarini has now reached important positions in Eastern and Central Europe where it ranks no. 6 in the total market of this region including: Russia, Poland, Ukraine, the Baltic States, Czech Rep., Romania, Kazakhstan, Bulgaria, Belarus, Hungary, Slovak Rep., Uzbekistan, the Caucasian countries, Albania, Moldova and ex-Yugoslavia. Menarini is the leader on the market in the Baltic States, Ukraine, Belarus and ranking no. 2 in Russia and Kazakhstan.
The Menarini Group is present in the most important therapeutic areas of greatest importance, including:
cardiovascular products
astro-intestinal productsantibiotics/respiratory system productsdrugs used in diabetes
anti-inflammatory agents/analgesics
and many others.Menarini is present in these therapeutic areas with numerous products that are representing up-todate therapeutic solutions for physicians and their patients. Given the lenght and complexity of our product list, individual lists for each country can be found at the relative company site, currently under preparation.
Menarini has been one of the first companies to have taken advantage of European decentralised registrations. Over the past nine years as many as ten products have been registered with this method. As proof of the quality of the products and of the registration dossiers presented, seven products were simultaneously registered in all Community member countries, which is quite a rare event.
In the international pharmaceutical market, today Menarini is a highly experienced company in new product registrations within the European area.
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life…
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market,…
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API…
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory…
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help…
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly…
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve…
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as…
Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare…
Jim Curley, the CEO of Jones Engineering Group, details the company’s more than 125-year history in Ireland and…